{"podcast":{"title":"The Meb Faber Show - Better Investing","slug":"the-meb-faber-show-better-investing-743157","podcast_index_feed_id":743157,"rss_url":"https://feeds.megaphone.fm/TIFM6133783130","website_url":"https://www.themebfabershow.com/","image_url":"https://megaphone.imgix.net/podcasts/dfd9a908-428f-11ee-a9c5-6fac729c68a0/image/1400x1400.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress","author":"The Idea Farm","episode_count":708,"summary":"Ready to grow your wealth through smarter investing decisions? With The Meb Faber Show, bestselling author, entrepreneur, and investment fund manager, Meb Faber, brings you insights on today’s markets and the art of investing. Featuring some of the top investment professionals in the world as his guests, Meb will help you interpret global equity, bond, and commodity markets just like the pros. Whether it’s smart beta, trend following, value investing, or any other timely market topic, each week you’ll hear real market wisdom from the smartest minds in investing today. Better investing starts here. For more information on Meb, please visit MebFaber.com. For more on Cambria Investment Management, visit CambriaInvestments.com.","last_synced_at":"2026-07-24T16:19:52.677138+00:00","page_url":"https://stenobird.com/podcast/the-meb-faber-show-better-investing-743157"},"episode":{"title":"Dan Rasmussen & D.A. Wallach on Biotech’s Surge, China, IPOs, US Valuations & Japan | #617","slug":"dan-rasmussen-d-a-wallach-on-biotech-s-surge-china-ipos-us-valuations-japan-617","published_at":"2026-02-09T09:30:00+00:00","page_url":"https://stenobird.com/podcast/the-meb-faber-show-better-investing-743157/dan-rasmussen-d-a-wallach-on-biotech-s-surge-china-ipos-us-valuations-japan-617","show_page_url":"https://stenobird.com/podcast/the-meb-faber-show-better-investing-743157","url":"https://traffic.megaphone.fm/TIFM9643870471.mp3?updated=1775780608","audio_url":"https://traffic.megaphone.fm/TIFM9643870471.mp3?updated=1775780608","summary":"Watch on YouTube. Today’s returning guests are Dan Rasmussen, founder of Verdad Advisers, and D.A. Wallach, a venture capital investor for Time BioVentures. In today’s episode, we unpack the recent biotech surge through the lens of Dan’s recently published biotech report. We also explore China’s growing biotech market, shifting IPO and VC trends, and how valuation tools like CAPE fit into today’s regime. Finally, we also discuss technology’s effect on productivity and corporate profits in the US, Japan’s economic anomaly, home country bias, and more. (0:00) Starts (1:20) Dan's research on the biotech sector (19:10) D.A. on biotech in China (27:01) IPO landscape (31:01) Biotech VC update from D.A. (32:16) Are US stocks overvalued? (51:53) Dan's view of Japanese stocks (57:40) Global equity markets and home country bias (1:03:34) Book recommendations (1:11:55) Wrap-up and future plans ----- Follow Meb on X, LinkedIn and YouTube For detailed show notes, click here To learn more about our funds and follow us, subscribe to our mailing list or visit us at cambriainvestments.com ----- ⁠ ----- Sponsor: Visit ⁠⁠Alpha Architect’s 351 Education Center⁠⁠ for use cases, tools, FAQs, upcoming launches, and more. Follow The Idea Farm: X | LinkedIn | Instagram | TikTok ----- Interested in sponsoring the show? Email us at Feedback@TheMebFaberShow.com ----- Past guests include Ed Thorp, Richard Thaler, Jeremy Grantham, Joel Greenblatt, Campbell Harvey, Ivy Zelman, Kathryn Kaminski, Jason Calacanis, Whitney Baker, Aswath Damodaran, Howard Marks, Tom Barton, and many more. ----- Meb's invested in some awesome startups that have passed along discounts to our listeners. Check them out here! ----- Editing and post-production work for this episode was provided by The Podcast Consultant (https…","meta_description":"Watch on YouTube. Today’s returning guests are Dan Rasmussen, founder of Verdad Advisers, and D.A. Wallach, a venture capital investor for Time BioVenture…","key_points":[],"chapters":[],"topics":[],"duration_seconds":4553,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-meb-faber-show-better-investing-743157/episodes/dan-rasmussen-d-a-wallach-on-biotech-s-surge-china-ipos-us-valuations-japan-617/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-meb-faber-show-better-investing-743157/dan-rasmussen-d-a-wallach-on-biotech-s-surge-china-ipos-us-valuations-japan-617.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}